Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Allergic Rhinitis Stories

2013-12-13 16:24:31

SAN ANTONIO, Dec. 13, 2013 /PRNewswire/ -- United Allergy Services (UAS)®, a leading healthcare services company assisting family physicians and health systems to deliver safe and effective allergy testing and customized immunotherapy services, today announced that data from a recent retrospective study citing the safety of UAS' protocols for seasonal and perennial allergy treatment in the primary care setting will be presented at the World Allergy Organization's (WAO) Annual...

2013-12-11 23:24:57

Allergy specialists, AllergyEasy, discusses how Christmas trees can trigger allergies and how the holidays can lead to suffering. Tempe, Arizona (PRWEB) December 11, 2013 While fall pollen allergies usually die down in winter, holiday traditions can introduce new challenges for allergy sufferers. The Christmas tree, for example, can be a prime source of misery. If someone is debating whether a real or artificial tree will be easier on allergies, here are some pros and cons. Real Trees:...

How Probiotics Could Affect Hay Fever
2013-11-26 11:42:05

Norwich BioScience Institutes A study has shown that a daily probiotic drink changed how cells lining the nasal passages of hay fever sufferers reacted to a single out-of-season challenge. However, it did not lead to significant changes in hay fever symptoms, although this challenge test may not have accurately represented natural allergen exposure. Our immune system must distinguish between "friends" that can be beneficial to our health and "foes" that can have harmful effects. There...

allergies cause more severe migraines
2013-11-25 12:51:29

Lee Rannals for redOrbit.com - Your Universe Online Researchers have found that those who suffer from migraines and battles allergies endure a more severe form of headache then their peers. According to findings published in the journal Cephalalgia, allergies and hay fever, or rhinitis, may cause more significant migraines. Migraines are three times more common in women than men, and about 12 percent of the US population experiences this harsh headache. Moreover, experts say that somewhere...

2013-10-01 04:22:32

OXFORD, England, October 1, 2013 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on developing world-class immunotherapies, today announced successful results from a large phase II clinical study of its ToleroMune(R) grass allergy treatment (Grass-Synthetic Peptide Immuno-Regulatory Epitope [Grass-SPIRE]). Patients who received a short course of treatment before the pollen season had significantly improved allergy symptoms at the end of the...

2013-09-17 12:29:20

Fall Allergy Capitals Report Ranks Most Challenging Cities for Allergies LANDOVER, Md., Sept. 17, 2013 /PRNewswire-USNewswire/ -- This fall could be a perfect storm for allergy sufferers, as global warming conditions boost ragweed levels and fall storms and tornadoes disperse allergens and outdoor mold, according to the Asthma and Allergy Foundation of America (AAFA). The 2013 Fall Allergy Capitals(TM) report released today by AAFA ranks the most challenging cities to live in with allergies...

2013-09-12 04:22:35

OXFORD, England, September 12, 2013 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced successful results from a phase II clinical study of its house dust mite allergy treatment (House Dust Mite-Synthetic Peptide Immuno-Regulatory Epitope [HDM-SPIRE] based on Circassia's ToleroMune(R) technology). Patients who received four doses of the treatment over 12 weeks had significantly improved allergy symptoms one year after the...

2013-09-04 08:31:44

MONMOUTH JUNCTION, N.J. and CHARLOTTE, N.C., Sept. 4, 2013 /PRNewswire/ -- Tris Pharma, Inc. and FSC Laboratories, Inc. today announced the signing of a definitive licensing agreement for the commercialization of Karbinal((TM)) ER (carbinoxamine maleate) Extended-release Oral Suspension 4 mg/5 ml, the first sustained-release histamine receptor blocking agent indicated for the treatment of seasonal and perennial allergic rhinitis in children ages 2 and up. Karbinal ER is expected to be...

2013-08-13 23:02:42

Akron General's Chief of Allergy Bela Faltay, MD, is available to provide practical coping tips. Infographic with relief tips included. Akron, OH (PRWEB) August 13, 2013 The record spring rains and the damp summer season occurring throughout the Midwest this year have resulted in conditions that are wreaking havoc on the eyes and the sinuses of allergy sufferers. This is due to the proliferation of weed pollen, particularly ragweed. "Ragweed season could potentially be more...

2013-07-31 20:21:31

- Treats Seasonal and Year-round Nasal Allergy Symptoms in Adults and Children - PARIS, July 31, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration's (FDA) Nonprescription Drugs Advisory Committee (NDAC) voted 10 to 6, with 2 abstentions, recommending approval of Nasacort(®) AQ Nasal Spray (triamcinolone acetonide) for over-the-counter use in the U.S. (Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO)...